The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I) (formula should be inserted here) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
-
Page/Page column 154; 155
(2010/01/30)
More Articles about upstream products of 1202705-82-5